American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$493M |
| 2 |
Colgate-Palmolive
CL
|
+$367M |
| 3 |
Microsoft
MSFT
|
+$328M |
| 4 |
Fidelity National Information Services
FIS
|
+$298M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WP
Worldpay, Inc.
WP
|
+$300M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$268M |
| 3 |
Medtronic
MDT
|
+$233M |
| 4 |
Intercontinental Exchange
ICE
|
+$201M |
| 5 |
STI
SunTrust Banks, Inc.
STI
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.66% |
| 2 | Technology | 16% |
| 3 | Healthcare | 15% |
| 4 | Consumer Discretionary | 11.58% |
| 5 | Industrials | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Stepan Co
SCL
$1.48B
| $3.85M | ﹤0.01% |
+39,638
| New | +$3.76M |
|
|
SPNS
852
DELISTED
Sapiens International
SPNS
| $3.84M | ﹤0.01% |
195,668
-98,633
| -34% | -$1.72M |
|
853
Inspire Medical Systems
INSP
$1.68B
| $3.84M | ﹤0.01% |
62,960
-24,728
| -28% | -$1.63M |
|
854
Financial Institutions
FISI
$825M
| $3.82M | ﹤0.01% |
126,637
+296
| +0.2% | +$8.67K |
|
|
VMW
855
DELISTED
VMware, Inc
VMW
| $3.8M | ﹤0.01% |
25,320
-239,338
| -90% | -$37.7M |
|
856
iShares Mortgage Real Estate ETF
REM
$543M
| $3.79M | ﹤0.01% |
+90,000
| New | +$3.8M |
|
857
Adient
ADNT
$1.44B
| $3.78M | ﹤0.01% |
+164,511
| New | +$3.75M |
|
858
OneMain Financial
OMF
$7.44B
| $3.77M | ﹤0.01% |
102,858
+10,657
| +12% | +$395K |
|
859
State Street SPDR S&P 500 ETF Trust
SPY
$809B
| $3.77M | ﹤0.01% |
12,700
-450,500
| -97% | -$133M |
|
860
PTC Therapeutics
PTCT
$6.06B
| $3.73M | ﹤0.01% |
110,314
+6,574
| +6% | +$286K |
|
|
PTLA
861
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $3.71M | ﹤0.01% |
138,255
+8,279
| +6% | +$232K |
|
862
East-West Bancorp
EWBC
$18.5B
| $3.68M | ﹤0.01% |
83,041
+23,574
| +40% | +$1.04M |
|
|
ESTE
863
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $3.63M | ﹤0.01% |
1,117,701
+93,538
| +9% | +$399K |
|
864
American Water Works
AWK
$26.8B
| $3.63M | ﹤0.01% |
+29,227
| New | +$3.52M |
|
|
FOLD
865
DELISTED
Amicus Therapeutics
FOLD
| $3.62M | ﹤0.01% |
451,372
+26,657
| +6% | +$289K |
|
|
ALE
866
DELISTED
Allete
ALE
| $3.61M | ﹤0.01% |
41,332
-46,908
| -53% | -$4.04M |
|
|
MDCO
867
DELISTED
Medicines Co
MDCO
| $3.61M | ﹤0.01% |
72,119
-22,466
| -24% | -$896K |
|
|
SAND
868
DELISTED
Sandstorm Gold
SAND
| $3.6M | ﹤0.01% |
637,100
-569,100
| -47% | -$3.46M |
|
869
Arrowhead Research
ARWR
$12.3B
| $3.59M | ﹤0.01% |
127,295
-53,398
| -30% | -$1.58M |
|
870
Pacira BioSciences
PCRX
$945M
| $3.57M | ﹤0.01% |
93,844
+2,926
| +3% | +$117K |
|
871
Hawaiian Electric Industries
HE
$2.06B
| $3.56M | ﹤0.01% |
78,095
-1,188
| -1% | -$52.8K |
|
|
BFS
872
Saul Centers
BFS
$850M
| $3.55M | ﹤0.01% |
65,052
+20,067
| +45% | +$1.07M |
|
873
Morgan Stanley
MS
$342B
| $3.54M | ﹤0.01% |
83,046
+64,511
| +348% | +$2.76M |
|
874
Iovance Biotherapeutics
IOVA
$3.05B
| $3.54M | ﹤0.01% |
+194,544
| New | +$4.3M |
|
875
Evolent Health
EVH
$471M
| $3.51M | ﹤0.01% |
488,018
-209,644
| -30% | -$1.5M |
|
Similar funds
American Century Companies's Q3 2019 Portfolio in Review
As of Q3 2019, American Century Companies held 1,407 positions worth $99.6B, down 0.83% from $100B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
American Century Companies's Q3 2019 filing shows 144 new, 546 increased, 497 reduced and 204 closed positions. Its largest new stake was A.O. Smith: 2,750,567 shares worth $131M. The largest sale was Worldpay, Inc., an estimated $300M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
- American Century Companies's largest Q3 2019 buy was A.O. Smith: 2,750,567 shares worth $131M.
- American Century Companies added most to Pfizer in Q3 2019, an estimated $493M increase.
- American Century Companies's biggest Q3 2019 reduction was Medtronic, cutting an estimated $233M.
- American Century Companies fully exited Worldpay, Inc. in Q3 2019, selling an estimated $300M.
- American Century Companies's ten largest holdings make up 18% of its $99.6B portfolio in Q3 2019.
- American Century Companies opened 144 new positions and closed 204 in Q3 2019.
- American Century Companies's portfolio value fell 0.83% quarter-over-quarter to $99.6B.
Based on American Century Companies's 13F filing for Q3 2019, filed 13 Nov 2019.